Topoisomerase Inhibitor [EPC]

76948 reported adverse events

Drugs of this class: ETOPOSIDE TOPOTECAN

These side effects are most commonly reported by patients taking drugs of the Topoisomerase Inhibitor [EPC] class:

# Side effect Count
0 OFF LABEL USE 8763
1 FEBRILE NEUTROPENIA 8088
2 NEUTROPENIA 5470
3 DRUG INEFFECTIVE 4931
4 DISEASE PROGRESSION 4863
5 THROMBOCYTOPENIA 4385
6 PYREXIA 3727
7 ANAEMIA 3689
8 PRODUCT USE IN UNAPPROVED INDICATION 3209
9 SEPSIS 3133
See all common reactions for Topoisomerase Inhibitor [EPC]

Drugs of the Topoisomerase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 292 0.3083
1 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 483 0.2188
2 VENOOCCLUSIVE LIVER DISEASE 650 0.1315
3 FEBRILE NEUTROPENIA 8088 0.1218
4 VENOOCCLUSIVE DISEASE 294 0.1173
5 ASPERGILLUS INFECTION 730 0.1111
6 NEUTROPENIC SEPSIS 761 0.1064
7 HAEMATOTOXICITY 956 0.1005
8 FEBRILE BONE MARROW APLASIA 418 0.0983
9 ACUTE MYELOID LEUKAEMIA 1505 0.0965
See all enriched reactions for Topoisomerase Inhibitor [EPC]